Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.275 CAD
−20.95 M CAD
0.00 CAD
25.73 M
About MYDECINE INNOVATIONS GROUP INC.
Sector
CEO
David Joshua Bartch
Headquarters
Vancouver
Website
Founded
2013
FIGI
BBG006Z3G1J1
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MYCO is 0.010 CAD — it hasn't changed in the past 24 hours. Watch MYDECINE INNOVATIONS GROUP INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange MYDECINE INNOVATIONS GROUP INC. stocks are traded under the ticker MYCO.
MYCO stock hasn't changed in a week, the month change is a 100.00% rise, over the last year MYDECINE INNOVATIONS GROUP INC. has showed a −91.67% decrease.
MYCO reached its all-time high on Jun 8, 2020 with the price of 1.150 CAD, and its all-time low was 0.005 CAD and was reached on Sep 4, 2024. View more price dynamics on MYCO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MYCO stock is 100.00% volatile and has beta coefficient of 6.73. Track MYDECINE INNOVATIONS GROUP INC. stock price on the chart and check out the list of the most volatile stocks — is MYDECINE INNOVATIONS GROUP INC. there?
Yes, you can track MYDECINE INNOVATIONS GROUP INC. financials in yearly and quarterly reports right on TradingView.
MYDECINE INNOVATIONS GROUP INC. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
MYCO net income for the last quarter is −1.99 M CAD, while the quarter before that showed −2.67 M CAD of net income which accounts for 25.40% change. Track more MYDECINE INNOVATIONS GROUP INC. financial stats to get the full picture.
No, MYCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYDECINE INNOVATIONS GROUP INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYDECINE INNOVATIONS GROUP INC. stock shows the neutral signal. See more of MYDECINE INNOVATIONS GROUP INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.